The bipartisan agreement could help stabilize insurance premiums next year so that younger, healthier people will buy policies. President Trump has embraced it, but other GOP leaders have not.
When Mike Moore was Mississippi's attorney general, he spearheaded the 50-state lawsuit against Big Tobacco. Now, he's trying to do the same thing against opioid manufacturers and distributors.
President Trump's nominee to head the Drug Enforcement Administration pulled out amid controversy. This leaves Trump without a permanent heads at Department of Health and Human Services and the DEA. All the while, his promised declaration of a national emergency on opioids has yet to materialize.
Enhancing a research monkey's life by housing it with a pal often doesn't hurt the study, says a researcher who's done it. In her own experience, she says, "it actually helped to improve the science."
Among the charges is conspiracy to distribute large quantities of fentanyl, a significant factor in the opioid crisis. Every year, thousands of Americans overdose on the drug.
Scientists looking for genetic factors behind obsessive compulsive disorder looked for clues in the DNA of humans and two animal species. Genes active in a particular brain circuit emerged.
With the enrollment period for the Affordable Care Act fast approaching and the president pushing forward on his promise to dismantle it, what's at stake?
The Republican congressman from Pennsylvania is withdrawing days after reports that legislation he sponsored hindered the Drug Enforcement Administration in its fight against the U.S. opioid crisis.
David Greene talks to Missouri Democrat Claire McCaskill about reports that President Trump's nominee to be the next drug czar, Republican Rep. Tom Marino, has deep ties to the drug industry.
Some employers may now opt to claim a religious or moral exemption when it comes to paying for birth control, and women could end up sharing the cost with employers that scale back coverage.